Cargando…
PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
PURPOSE: The aim of this study was to investigate the effect of phosphotyrosine interaction domain containing 1 (PID1) on the insulin-induced activation of the AKT (protein kinase B)/protein kinase A (PKA)/hormone-sensitive lipase (HSL) pathway and lipolysis. METHODS: Sprague–Dawley rats were fed ei...
Autores principales: | Yin, Chunyan, Liu, Wei hua, Liu, Yuesheng, Wang, Li, Xiao, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467375/ https://www.ncbi.nlm.nih.gov/pubmed/30990811 http://dx.doi.org/10.1371/journal.pone.0214606 |
Ejemplares similares
-
Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019) -
A NOVEL INDEX OF WHOLE BODY ANTILIPOLYTIC INSULIN ACTION
por: Van Pelt, R.E., et al.
Publicado: (2013) -
Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells
por: Carpéné, Christian, et al.
Publicado: (2017) -
A longitudinal study of the antilipolytic effect of insulin in women following bariatric surgery
por: Kwok, Kelvin Ho Man, et al.
Publicado: (2021) -
The acute effects of growth hormone in adipose tissue is associated with suppression of antilipolytic signals
por: Høyer, Katrine L., et al.
Publicado: (2020)